Monday November 23 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Clontech Laboratories, Inc

Clontech Laboratories, Inc. develops, produces, and markets innovative biological products to the life science market worldwide. Clontech is a wholly owned subsidiary of Takara Bio, Inc.


Contact Details:
1290 Terra Bella Avenue
Mountain View
California
94043
United States of America
Tel:800-662-2566
Fax:650-424-1352
Email:orders@clontech.com
WWW:

www.clontech.com/




Loading...

Press Releases on Clontech Laboratories, Inc:

BioPortfolio Logo
Clontech Laboratories, Inc. Releases the Xfect(TM) and Xfect(TM) Stem Transfection Reagents 28th May, 2009 Clontech Laboratories, Inc.
MOUNTAIN VIEW, Calif., May 28 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., today announced the upcoming (June 1, 2009) release of the Xfect(TM) and Xfect
TET Systems Signs License Agreement With Stemgent 11th February, 2009 TET Systems Holding
- Stemgent (www.stemgent.com) to market dox-inducible stem cell reprogramming reagents - HEIDELBERG, Germany, and SAN DIEGO, Feb. 11 /PRNewswire/ -- TET Systems Holding, a privately-held, Heidelberg
Clontech Laboratories, Inc. Recognizes the 2008 Winners of the Nobel Prize in Chemistry 14th October, 2008 Clontech Laboratories, Inc.
MOUNTAIN VIEW, Calif., Oct. 14 /PRNewswire/ -- Clontech Laboratories, Inc., a wholly-owned subsidiary of Takara Bio Inc., applauds the three winners of the 2008 Nobel Prize in Chemistry; Drs.

BioNews Results for Clontech Laboratories, Inc:

Antares Pharma, Inc. - Medical Equipment - Deals and Alliances Profile - new report released
PR inside:  Nov 16 2009 5:23AM Matching: laboratories inc
Antares Pharma, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - new report
PR inside:  Nov 16 2009 5:23AM Matching: laboratories inc
Abbott's Niaspan Reverses Artery Narrowing Versus Zetia
Lloyd's:  Nov 16 2009 12:22AM Matching: laboratories inc
Abbott's Niaspan Reverses Artery Narrowing Versus Zetia
CNN Money:  Nov 15 2009 11:30PM Matching: laboratories inc
Abbott's Niaspan Reverses Artery Narrowing Versus Zetia
Nasdaq:  Nov 15 2009 11:28PM Matching: laboratories inc
Promote your company here: BioNewsCast - Press Release Distribution

View more Clontech Laboratories, Inc news.

Clontech Laboratories, Inc Patents:

US Patent No.Title
5942610 Non-nucleoside 1,3-diol reagents and their use to label or modify synthetic oligonucleotides
6287768 Polymeric arrays and methods for their use in binding assays
6300073 One step RT-PCR methods, enzyme mixes and kits for use in practicing the same
6306600 Rapidly degrading GFP-fusion proteins and methods of use
6352829 Methods of assaying differential expression

View more Clontech Laboratories, Inc patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 297 times since April 2007, the link to the organisation's website has been followed 56 times

Recent Search Terms used to find this page: clontech | clont | CLONTECH | CLONTECH | .

Search for more companies in Mountain View

Search for more companies in California



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Clontech Laboratories, Inc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.